This was achieved by modulating the bile acid metabolites of the intestinal flora through the FXR–FGF15–FGFR4 axis, thereby activating Treg cells in vivo and alleviating the inflammatory state associated with diabetes. This evidence concerns the gene FGFR4 and diabetes mellitus.